Agrawal, U., Kumari, N., Vasudeva, P., Mohanty, N., & Saxena, S. (2018). Overexpression of COX2 indicates poor survival in urothelial bladder cancer. Annals of Diagnostic Pathology, 34, 50-55. https://doi.org/10.1016/j.anndiagpath.2018.01.008

Kumari, N., Agrawal, U., Mishra, A., Kumar, A., Vasudeva, P., Mohanty, N., & Saxena, S. (2017). Predictive role of serum and urinary cytokines in invasion and recurrence of bladder cancer. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine, 39(4), 1010428317697552. https://doi.org/10.1177/1010428317697552

Agrawal, U., Kumari, N., Mishra, A., Vasudeva, P., Kumar, A., Mohanty, N., & Saxena, S. (2016). Immune signature of urothelial cancer associated with grade, recurrence, and invasion. Urologic Oncology, 34(9), 418.e17-26. https://doi.org/10.1016/j.urolonc.2016.04.013

Kumari, N., Saxena, S., & Agrawal, U. (2015). Exosomal protein interactors as emerging therapeutic targets in urothelial bladder cancer. Journal of the Egyptian National Cancer Institute, 27(2), 51-8. https://doi.org/10.1016/j.jnci.2015.02.002